Nissay Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Nissay Asset Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,156	Closed	-$1.19M	–	745
2020 Q3	$1.19M	Buy	4,156 +231	+6%	+$54.3K	0.02%	488
2020 Q2	$739K	Buy	3,925 +593	+18%	+$96.5K	0.01%	594
2020 Q1	$410K	Buy	3,332 +422	+15%	+$66K	0.01%	620
2019 Q4	$482K	Sell	2,910 -153	-5%	-$25.4K	0.01%	671
2019 Q3	$375K	Buy	3,063 +161	+6%	+$21.4K	0.01%	686
2019 Q2	$360K	Buy	2,902 +149	+5%	+$18.9K	0.01%	702
2019 Q1	$363K	Buy	2,753 +127	+5%	+$17.1K	0.01%	683
2018 Q4	$368K	Buy	+2,626	New	+$348K	0.01%	658

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Nissay Asset Management's ONC Position: Q4 2020 in Review

Nissay Asset Management sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 4,156 shares — an estimated $1.19M sold.

Nissay Asset Management first reported a position in ONC in Q4 2018 and held it in 8 quarters. The position peaked at $1.19M in Q3 2020. 248 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

Nissay Asset Management reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
Nissay Asset Management sold 4,156 BeOne Medicines Ltd shares in Q4 2020, an estimated $1.19M.
Nissay Asset Management first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 8 quarters.
Nissay Asset Management's BeOne Medicines Ltd position peaked at $1.19M in Q3 2020.
248 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on Nissay Asset Management's 13F filing for Q4 2020, filed 8 Feb 2021.